The IMID Forum

A preview of the latest research at EULAR 2020.

Prof Bijlsma presents a preview of the upcoming EULAR 2020 congress, highlighting important abstracts in cytokine signalling.

Prof Iain McInnes discusses PsA & Hep B.

Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed in this podcast is available in a more detailed slide format in the publications section at cytokinesignalling.com.

The global effort improving patient outcomes amid COVID-19.

Prof Peter Nash discusses the global rheumatology register for COVID-19 with Prof Philip Robinson.

Prof Iain McInnes discusses vasculitis and zoster.

Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed in this podcast is available in a more detailed slide format in the publications section at cytokinesignalling.com.

Prof Kevin Winthrop from Oregon Health & Science University.

Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition Prof Kevin Winthrop discusses the long-term effectiveness of the live zoster vaccine.

The global effort improving patient outcomes amid COVID-19.

Past President of EULAR Prof Johannes Bijlsma discusses global rheumatology registries for COVID-19 with EULAR registry group member Prof Kimme Hyrich.

COVID-19 guidance for rheumatologists.

Prof Peter Nash discusses the challenges COVID-19 poses with infections specialist Prof Kevin Winthrop.

First to identify destructive properties of IL-17 and received the prestigious Carol Nachman prize in 2010 for his contribution. In this podcast, Prof Pierre Miossec discusses the pathophysiology of RA alongside Prof Tsutomu Takeuchi from Keio University.

Perspectives in Inflammation is a series of in-depth interviews revealing what attracted world leading experts to the field of inflammation, their current research interests, and views on the latest developments in inflammation.

Timo Gaber and Paula Hoff from Charité Berlin.

Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, the impact of tofacitinib on the bone healing process is discussed.

Prof Schett from University of Erlangen-Nuremberg.

Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Prof Schett discusses how JAK inhibitors can increase bone formation by stimulating osteoblasts.